CrossrefInfokarte
Corrigendum to “Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies” [Cancer Treat. Rev. 139 (2025) 102980]
Cancer Treatment Reviews · 2026-12 · 151 · 103238
DOI: 10.1016/j.ctrv.2026.103238 ↗Abstract
Kein Abstract verfügbar.
EUVIMED